Fairview Clinics
Fairview Clinics was paid $2.91M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
EAGAN, MN 55121
Next to other Urgent Care Clinic/Center providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,937 | $146K | |
| 2019 | 15,985 | $492K | |
| 2020 | 9,682 | $341K | |
| 2021 | 18,800 | $735K | |
| 2022 | 14,102 | $586K | |
| 2023 | 7,905 | $346K | |
| 2024incomplete | 6,079 | $267K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 16,161 | 14,627 | $1.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 18,430 | 17,092 | $864K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.1% | 2,371 | 2,316 | $177K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.8% | 1,699 | 1,658 | $110K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.3% | 2,125 | 2,055 | $96K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.9% | 2,548 | 2,488 | $85K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.8% | 2,164 | 2,119 | $52K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.8% | 4,541 | 4,369 | $52K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 1,847 | 1,772 | $51K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 488 | 445 | $49K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 10,784 | 9,763 | $35K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,334 | 2,217 | $26K |
73 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 312 | $20K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,322 | $16K |
| 80053 | Comprehensive metabolic panel | <1% | 1,687 | $15K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 206 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 943 | $12K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 143 | $12K |
| 80061 | Lipid panel | <1% | 1,070 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,200 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 333 | $10K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 303 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 631 | $10K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 93 | $9K |
| 87081 | <1% | 1,815 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,484 | $9K |
| 90686 | <1% | 1,507 | $8K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 140 | $8K |
| X5622 | <1% | 941 | $8K | |
| 96127 | <1% | 1,372 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 100 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 120 | $6K |
| 85027 | <1% | 890 | $5K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 70 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 178 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 537 | $4K |
| 99188 | <1% | 477 | $4K | |
| 87210 | <1% | 697 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 139 | $3K |
| 81001 | <1% | 1,244 | $3K | |
| 92551 | <1% | 604 | $3K | |
| 92015 | Determination of refractive state | <1% | 334 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 413 | $3K |
| 86803 | <1% | 153 | $2K | |
| 99000 | <1% | 143 | $2K | |
| 90682 | <1% | 51 | $2K | |
| 99421 | <1% | 310 | $1K | |
| 99442 | <1% | 58 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $1K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 65 | $1K |
| 90715 | <1% | 92 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 24 | $1K |
| 90480 | <1% | 45 | $1K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 46 | $1K |
| 90651 | <1% | 31 | $980.11 | |
| 91320 | <1% | 12 | $917.08 | |
| 90656 | <1% | 116 | $912.11 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $705.24 |
| 99173 | <1% | 659 | $655.03 | |
| 0071A | <1% | 14 | $560.14 | |
| 0004A | <1% | 15 | $546.15 | |
| 99443 | <1% | 19 | $545.24 | |
| 82728 | <1% | 37 | $504.14 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 13 | $486.44 |
| 87807 | <1% | 34 | $450.05 | |
| 93000 | <1% | 55 | $390.26 | |
| 0124A | <1% | 13 | $360.53 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 12 | $328.34 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 63 | $263.91 |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 13 | $258.16 |
| 81025 | <1% | 28 | $229.37 | |
| 36416 | <1% | 86 | $214.93 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 129 | $202.99 |
| 81003 | <1% | 91 | $172.04 | |
| G0008 | Administration of influenza virus vaccine | <1% | 28 | $138.64 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17 | $138.30 |
| 90734 | <1% | 13 | $120.73 | |
| 82043 | <1% | 12 | $69.25 | |
| 84439 | <1% | 14 | $33.01 | |
| 84703 | <1% | 13 | $9.83 | |
| 85652 | <1% | 31 | $0.20 | |
| 90670 | 0% | 25 | $0.00 | |
| 90685 | 0% | 40 | $0.00 | |
| 90633 | 0% | 12 | $0.00 | |
| 90698 | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.